Effect of bisdemethoxycurcumin on staurosporine-induced apoptosis in cardiomyocytes

Xing LI,Cong HUO,Yan LIU,Rong XU,Yue-Sheng XIA,Xin JIA,Xiao-Ming WANG
DOI: https://doi.org/10.11915/j.issn.1671-5403.2017.01.013
2017-01-01
Abstract:Objective To determine the effect of bisdemethoxycurcumin ( BDMC ) on the apoptosis of primary cardiomyocytes induced by staurosporine (STS).Methods Myocardial cells were isolated from neonatal C57BL/6J mice and then primarily cultured. Then the obtained cells were divided into control group , STS treatment group , BDMC pretreatment +STS treatment group and BDMC pretreatment group.Cell viability, cell apoptosis, caspase-3 activity, and intracellular reactive oxygen species (ROS) level were measured by CCK-8 assay, TUNEL assay kit, caspase-3 activity assay kit and ROS assay kit , respectively.Results Pretreatment of 100 μmol/L BDMC resulted in significantly increased cell viability , obviously decreased caspase-3 activity, remarkably lowered apoptosis rate and notably reduced ROS level ( P <0.05) in the cardiomyocytes.Conclusion BDMC can inhibit cell apoptosis through decreasing the intracellular ROS level in the cardiomyocytes , so as to protect the cells against STS-induced injury.
What problem does this paper attempt to address?